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Figure 3. Cytokine proﬁles from co-culture cultured with or without Triamcinolone cytokine proﬁle day 11).
alone (Fig. 1). Addition of Triamcinolone to the co-culture inhibited these
catabolic effects of synovial tissue on cartilage on GAG content (Fig. 2).
Cytokine proﬁles from the culture medium showed that both tissues
secreted cytokines. In cartilage cultured alone some cytokine that are
normally present in synovial ﬂuid of OA patients were not detected in the
medium. In the co-culture of cartilage and synovial tissue most cytokines
were present, indicating that for mimicking the osteoarthritic environment
both tissues are required. Addition of Triamcinolone decreased the amount
of cytokines released by the cartilage as well as the cytokines from the
synovial tissue (Fig. 3).
Conclusions: From the present data, we conclude that it is possible to
culture synovial tissue explants for at least 21 days. A co-culture with
synovial tissue explants enhances GAG release by the cartilage explants,
indicating the catabolic environment that is present in OA is mimicked
more closely in co-culture than in single explant culture. We demonstrate
the possibility to modulate this breakdown on both cartilage as synovial
tissue level by adding Triamcinolone. This study indicates the applicability
of this co-culture model to study the interaction between cartilage and
synovial tissue. Furthermore this model can be used for screening new
modulators of cartilage degeneration in OA.
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R.T. Sheldon, W. Sun, P.S. Chockalingam, M. Rivera-Bermudez,
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Purpose: Osteoarthritis (OA) features an imbalance of anabolic and
catabolic processes, ultimately resulting in loss of function and destruction
of cartilage. The major proteoglycan of articular cartilage, aggrecan, pro-
vides impact absorption and load bearing properties to the tissue. In OA,
ADAMTS-4 and ADAMTS-5 are key enzymes responsible for the degradation
of aggrecan. We have previously demonstrated that oral treatment with
an Aggrecanase Selective Inhibitor (ASI) in a rat model of joint injury/OA
is chondroprotective. Cytokine-induced bovine articular cartilage explants
are a common in vitro model of cartilage degradation, whereas in vitro
rat cartilage explant assays have not been extensively described. This
study investigated whether rat articular cartilage can be induced to release
aggrecan in response to catabolic stimuli, and whether the induction can
be attenuated by treatment with ASI.
Methods: Individual femoral head cartilage explants from approximately
3-week old male Lewis rats were cultured in 96-well plates. Treatments of
six wells per group consisted of a variety of cytokines or all-trans retinoic
acid (RA), +/- ASI (dose ranging between ∼80-5200nM) were cultured for
3 days with daily media exchange. Residual explants were digested with
1mg/ml proteinase K and aggrecan sGAG release was determined by assay-
ing culture media and cartilage extracts using DMMB. sGAG release was
normalized per cartilage weight and as a percentage of total sGAG per well.
Aggrecan cleavage by aggrecanases was measured by 374ARGN-aggrecan
ELISA as previously described. Relative cellular activity was determined
using a lactate colorimetric assay.
Results: Initial studies compared a number of induction conditions to iden-
tify a treatment that resulted in the greatest release of sGAG and 374ARGN
neoepitope in rat hip cartilage explant culture. Human TNF-α (100ng/ml),
IL-1α +/- OSM (both 10ng/ml) as well as mouse IL-1α and β (10ng/ml) failed
to signiﬁcantly induce sGAG release. Treatment with rat IL-1α and β and
human IL-1β (all 10ng/ml) resulted in an induction window of sGAG release
of 2× over background. The greatest induction by day 3 was generated
with 1 or 10μM RA resulting in ∼3× above background sGAG and 10-30×
374ARGN neoepitope. Lactate levels in conditioned media indicated that all
treatments were well tolerated as cellular activity was within 85% of the
media group. Treatment of explants with 1μM RA in the presence of ASI
resulted in dose-dependent inhibition of both sGAG and ARGN-aggrecan
release, demonstrating that sGAG release is aggrecanase-mediated, as in
bovine explant culture systems.
Conclusions: Similar to previously established bovine models, rat articular
cartilage can be induced to catabolize aggrecan in an aggrecanase-
dependent process, which can be prevented by treatment with an ag-
grecanase inhibitor. Since relative differences in ADAMTS-4 or ADAMTS-5
activities may exist between species, this assay will be useful as a tool
for pre-screening and selection of compounds for evaluation in rat in vivo
models.
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Purpose: Joint immobilization is a useful and commonly performed
treatment modality in orthopedics, however, it also causes unfavorable
outcomes such as joint contracture, periarticular osteoporosis, and cartilage
degeneration. Once joint contracture is established, it is extremely diﬃcult
to regain a full range of motion (ROM) with vigorous and extensive rehabil-
itation, or even with surgical treatment. Joint contracture is classiﬁed into
two types according to its etiology: arthrogenic (bone, cartilage, synovial
membrane, capsule, and ligaments) and myogenic (muscle, tendon, and
fascia). Some investigators insisted on an importance of the myogenic
components, whereas others did on the arthrogenic ones. Among the
arthrogenic components, capsular stiffness might contribute more to joint
contracture than the other ones. In our previous study, ROM after total
extra-articular myotomies was increased after the capsular release, which
indicated the capsule was one of the main causes of joint contracture.
Determination of the expression levels of structural collagens (collagen
types I and III), and ﬁbrogenetic factors, such as connective tissue growth
factor (CTGF) and transforming growth factor-β1 (TGF-β1) are a key to un-
derstand the elastic changes of the capsule. The purpose of this study was
to elucidate expression patterns of the capsule after joint immobilization
in a rat knee ﬂexion contracture model by multidirectional approach.
Methods: Unilateral knee joints of adult male Sprague-Dawley rats (body
weight, 380-400 g) were rigidly immobilized at 150° of ﬂexion with a
plate and screws for various periods (3 days, 1, 2, 4, 8, and 16 weeks).
Sham-operated animals had holes drilled in the femur and tibia with
screws inserted without a plate. The immobilized animals and the sham-
operated animals made up the immobilized group and the control group,
respectively. Five-μm sections at the medial midcondylar region in sagittal
plane were obtained for in situ hybridization (ISH) and immunohistochem-
istry (IHC). The capsules, without tendons, ligaments, and muscles, were
obtained with a surgical knife for quantitative PCR (qPCR) and Western
blotting (WB). Collagen types I and III were evaluated by ISH, qPCR, IHC,and
WB. CTGF and TGF-β1 were investigated by ISH and IHC.
Results: Expressions of collagen types I and III were decreased after immo-
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bilization compared to the control group by ISH and qPCR. The expression
was not changed after immobilization compared to the control group by
IHC and WB. Expressions of CTGF and TGF-β1were increased after the ﬁrst
2-week immobilization and then decreased by ISH, and increased gradually
by IHC compared to the control group.
Conclusions: The expression of mRNAand protein levels of collagen types
I and III were not increased after immobilization, which indicated that
accumulation of the two types of collagen was not the etiology of joint
contracture. However, ﬁborogenetic factors of CTGF and TGF-β1 were
increased. Another process, such as capsule and synovial adhesions or
collagen cross-linking, may be possible causes of joint contracture.
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PROSTAGLANDIN D2 ENHANCES INTERLEUKIN -1BETA- INDUCED
CYCLOOXYGENASE-2 EXPRESSION IN OSTEOARTHRITIC SYNOVIOCYTES
N. Zayed, N. Chabane, F. El Mansouri, J. Martel-pelletier, J.-P. Pelletier,
h. Fahmi
Montreal Univ., Montreal, QC, Canada
Purpose: To investigate the effects of prostaglandin D2 (PGD2) on
interleukin-1beta (IL-1beta)-induced cyclooxygenase (COX)-2 expression
in human synoviocytes and the signalling pathways involved in these
effects.
Methods: Synoviocytes were stimulated with IL-1 in the presence or
absence of PGD2, and expression of COX-2 protein was evaluated by
western-blotting. Messenger RNA (mRNA) expression was analyzed by
real-time reverse transcription-polymerase chain reaction. The role of
the PGD2 receptors D prostanoid receptor 1 (DP1) and chemoattractant
receptor-like molecule expressed on Th2 cells (CRTH2) was evaluated using
speciﬁc agonists.
Results: PGD2 increased in a dose-dependent manner IL-1-induced COX-2
protein and mRNA expression. DP1 and CRTH2 were expressed and func-
tional in synoviocytes. The effect of PGD2 was mimicked by DK-PGD2 and
Indomethacin, selective agonists of CRTH2, but not by BW245C, a selective
agonist of DP1. Furthermore, treatment with an anti-CRTH2 antibody re-
versed the effect of PGD2, indicating that the stimulatory effect of PGD2
is mediated by CRTH2. Activation of CRTH2 is consistent with the activa-
tion of a receptor coupled to a phosphoinositide-speciﬁc phospholipase,
suggesting that the effect of PGD2 is mediated by the CRTH2/PIP2/PKC.
Conclusions: PGD2 enhances IL-1-induced production of COX-2 by syn-
oviocytes through the CRTH2/PIP2/PKC signalling pathway.
Matrix Biochemistry
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Purpose: To determine differences between well-deﬁned OA and control
human articular cartilage samples in type III collagen content.
Methods: Full-depth, intact surface cartilage from 5 OA (aged 60-80, 4
women) and 5 reference (aged 78-87, 5 women) femoral heads were
obtained at total hip replacement surgery for osteoarthritis (OA) or femoral
neck fracture.
1 mg/ml α-chymotrypsin plus inhibitors was added to each diced sample
(incubated at 32°C overnight) to remove susceptible collagen components.
An aliquot of the supernatant was freeze-dried and used for SDS-PAGE
and another aliquot was hydrolyzed in 6M HCl at 110°C to be assayed for
hydroxyproline (μg/mg wet wt.) colorimetrically.
SDS-PAGE and Western blots were run using mAb 1C10, which recognizes
a sequence-speciﬁc epitope in α1(II) CB9,7 and mAb 4G9, which recognizes
a conformational epitope in the collagen III N-propeptide domain.
A competition ELISA was run on the same extracts using the 4G9 mAb
to quantify the collagen III N-propeptide levels extracted from OA and
reference cartilage samples.
Results: There was more extractable collagen in the OA than in the
reference cartilage, 5% and 2%, respectively (p=0.02).
From OA and normals, most of the extracted collagen ran as intact α1(II)
chains and large fragments on mAb 1C10 SDS-PAGE/Western (Fig. 2A).
Figure 1. Model of Type III collagen polymerized on Type II collagen ﬁbrils.
The major band stained in the SDS-PAGE/4G9 Western blot is the
cleaved N-propeptide trimer of collagen III released from the matrix by
α-chymotrypsin (Fig. 2B).
The ELISA results show a ﬁve-fold higher mean content of type III collagen
in OA hip cartilage versus fracture hip controls (Fig. 2B).
Figure 2. A. SDS-PAGE/Western blot of collagen type II in articular cartilage chy-
motrypsin extracts. B. SDS-PAGE/Western blot and an ELISA analysis of collagen type III
N-propeptide domain released from articular cartilage by chymotrypsin.
Conclusions: Our study conﬁrms previous results showing an increased
pool of extractable collagen in OA. In the present study we additionally
show that this extractable pool includes degradation products of type III
collagen.
The results show that grossly normal looking cartilage from joints under-
going degenerative disease (OA) develops a signiﬁcantly altered collagen
phenotype as shown by the synthesized and deposited collagen III in the
matrix of the OA compared with non-OA joints of similar age.
Previously it has been suggested that collagen III is made by the condro-
cytes in response to matrix damage similar to the wound-healing role of
collagen III in type I collagen-based tissues.
The covalent addition of collagen III to the ﬁbrillar matrix that occurs
in both normal and OA human articular cartilage suggests an active
remodeling process.
It remains to be established if increased amount of collagen III at sites of
superﬁcially intact, full thickness OA cartilage reﬂects pathological activity,
an active repair mechanism or both.
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Purpose: Stiffening of the joint is one of the features of knee osteoarthritis,
which can be caused by ﬁbrosis of the synovial tissue within the joint.
In this study, we investigated whether the adipose tissue in the joint
(infrapatellar fat pad) excretes cytokines and growth factors that could be
involved in ﬁbrosis.
